Clinical Trial Update: Self-Scored Cardiovascular Disease Risk Appraisal

View source ↗

Summary

This clinical trial update notes that an NHLBI-sponsored study evaluating a self-scored cardiovascular disease risk appraisal has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Heart Disease
• Heart Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED